| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 5 Feb 25 | IMRX Immuneering | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 1.91 | 100,000 | 191.00 k | 100,000 |
| 21 May 24 | IMRX Immuneering | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 3.01 | 60,500 | 182.11 k | 60,500 |
| 21 May 24 | IMRX Immuneering | Stock Option Class A Common Stock | Sale back to company | Dispose D | No | No | 6.09 | 60,500 | 368.45 k | 0 |
| 21 May 24 | IMRX Immuneering | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 3.01 | 165,000 | 496.65 k | 165,000 |
| 21 May 24 | IMRX Immuneering | Stock Option Class A Common Stock | Sale back to company | Dispose D | No | No | 9.71 | 165,000 | 1.60 mm | 0 |
| 22 Mar 24 | IMRX Immuneering | Class A Common Stock | Buy | Acquire P | No | No | 2.568 | 3,900 | 10.02 k | 3,900 |
| 8 Feb 24 | IMRX Immuneering | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 6.09 | 60,500 | 368.45 k | 60,500 |
